Anxiety Disorders Clinical Trials

A listing of Anxiety Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

View More ▼

San Diego California 92093

Patients are needed to participate in a clinical research study evaluating Alprazolam (Xanax) and Placebo for the treatment of Generalized Anxiety Disorder

Florida

NEW

APG Research LLC
Orlando Florida 32803

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Orlando Florida 32816

A clinical research study of Pegasys-VR and Social Effectiveness Therapy for Children for the treatment of Anxiety Disorders

Illinois

Rush University Medical Centre
Chicago Illinois 60612

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Chicago Illinois 60612

A Phase 2 clinical study for patients with Phobic Disorders

Maryland

Baltimore Maryland 21218

A clinical trial seeking patients for a research study for the treatment of Anxiety or Panic Disorder

Bethesda Maryland 20892

A clinical research study of SRX246 and Placebo for the treatment of Fear or Anxiety

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

OCD and Related Disorders Program
Boston Massachusetts 02114

Transcranial Magnetic Stimulation in Obsessive Compulsive Disorder: mechanisms and biomarkers.

View More ▼

Boston Massachusetts 02114

A Phase 2 clinical study for patients with Phobic Disorders

Natick Massachusetts 01760

A Phase 2 clinical study for patients with Phobic Disorders

New York

The Medical Research Network, LLC
New York New York 10128

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

NEW

Finger Lakes Clinical Research
Rochester New York 14618

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

NEW

Richmond Behavioural Associates
Staten Island New York 10312

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

New York New York 10128

A Phase 2 clinical study for patients with Phobic Disorders

Rochester New York 14618-1609

A Phase 2 clinical study for patients with Phobic Disorders

Pennsylvania

Lehigh Center For Clinical Research
Allentown Pennsylvania 18104

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Allentown Pennsylvania 18104

A Phase 2 clinical study for patients with Phobic Disorders

Texas

FutureSearch Trials of Dallas
Dallas Texas 75231

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Dallas Texas 75231

A Phase 2 clinical study for patients with Phobic Disorders

Utah

Optimum Clinical Research, Inc.
Salt Lake City Utah 84102

Irritable Bowel Syndrome - Diarrhea Predominant

Australia

UPDATED

Lyell McEwin Hospital
Elizabeth Vale International 5112

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

Peninsula Therapeutic and Research Group
Frankston International 3199

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Adelaide 5112

A Phase 2 clinical study for patients with Phobic Disorders

Frankston 3199

A Phase 2 clinical study for patients with Phobic Disorders

Melbourne 3121

A Phase 2 clinical study for patients with Phobic Disorders

Perth 6009

A Phase 2 clinical study for patients with Phobic Disorders

Canada

Chokka Center for Integrative Health
Alberta International 5112

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

Anxiety and Mood Disorder Center
Mississauga International L5M 4N4

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder

View More ▼

Edmonton Alberta T6L 6W6

A Phase 2 clinical study for patients with Phobic Disorders

Hamilton Ontario L8S 1B7

A Phase 2 clinical study for patients with Phobic Disorders

Mississauga Ontario L5M 4N4

A Phase 2 clinical study for patients with Phobic Disorders

Toronto Ontario M4Y 1H1

A clinical trial to evaluate treatments using Pregabalin and Placebo for patients with Anxiety

Toronto Ontario M6J 1H4

A Phase 2 clinical study for patients with Phobic Disorders

Wolfville Nova Scotia B4P 2R6

A clinical trial to evaluate treatments using L. helveticus R0052 and B. longum R0175 and Placebo for patients with Attention Deficit Hyperactivity Disorder or Anxiety

China

Shanghai 200065

A Phase 4 clinical study for patients with Generalized Anxiety Disorder

France

Paris 75000

A clinical research study of Phytostandard® Eschscholtzia / Valerian for the treatment of Sleep Disorders Related to Anxiety

Kazakhstan

Shymkent 160019

A Phase 4 clinical study for patients with Anxiety

Russian Federation

Chelyabinsk 454048

A Phase 4 clinical study for patients with Anxiety

Kazan' 420012

A Phase 4 clinical study for patients with Anxiety

Kazan' 420101

A Phase 4 clinical study for patients with Anxiety

Kazan' 420110

A Phase 4 clinical study for patients with Anxiety

Korolev 141060

A Phase 4 clinical study for patients with Anxiety

View More ▼

Moscow 115516

A Phase 4 clinical study for patients with Anxiety

Moscow 119992

A Phase 4 clinical study for patients with Anxiety

Moscow 115419

A Phase 4 clinical study for patients with Anxiety

Novosibirsk 630064

A Phase 4 clinical study for patients with Anxiety

Saint Petersburg 197022

A Phase 4 clinical study for patients with Anxiety

Samara 443096

A Phase 4 clinical study for patients with Anxiety